D. Piani-Meier

A Novel, Integrative Approach for Evaluating Progression in Multiple Sclerosis: Development of a Scoring Algorithm

T. Ziemssen, F. Dahlke, B. Bennett, 2020, JMIR medical informatics.

Siponimod vs placebo in active secondary progressive multiple sclerosis: a post hoc analysis from the phase 3 EXPAND study

D. Arnold, L. Kappos, P. Vermersch, 2022, Journal of Neurology.

Effect of siponimod on magnetic resonance imaging measures of neurodegeneration and myelination in secondary progressive multiple sclerosis: Gray matter atrophy and magnetization transfer ratio analyses from the EXPAND phase 3 trial

D. Arnold, L. Kappos, P. Vermersch, 2022, Multiple sclerosis.

Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey

P. Vermersch, M. Trojano, T. Ziemssen, 2021, Journal of medical Internet research.

Long-term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data up to >5 years

D. Arnold, L. Kappos, P. Vermersch, 2022, Multiple sclerosis.

114  Effect of siponimod on cognitive processing speed in SPMS patients with active and non-active disease

R. Gold, B. Cree, S. Ritter, 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

Learning ability correlates with brain atrophy and disability progression in RRMS

M. Sormani, L. Kappos, G. Giovannoni, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study

M. Freedman, T. Ziemssen, F. Dahlke, 2020, Journal of medical Internet research.

Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence

F. Dahlke, M. Bigaud, K. Shakeri-Nejad, 2022, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Predicting risk of secondary progression in multiple sclerosis: A nomogram

Markus R. Lange, F. Zhu, R. Carruthers, 2018, Multiple sclerosis.

Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey

P. Vermersch, M. Trojano, T. Ziemssen, 2021, Journal of medical Internet research.

A mixed methods approach towards understanding key disease characteristics associated with the progression from RRMS to SPMS: Physicians' and patients' views.

T. Ziemssen, B. Bennett, D. Tomic, 2019, Multiple sclerosis and related disorders.

Improvement in Cognitive Processing Speed With Ofatumumab in Patients With Relapsing Multiple Sclerosis (P6-3.005)

Jeffrey A. Cohen, L. Kappos, R. Benedict, 2023, Monday, April 24.